Home › NDC Lookup › RxCUI directory › RxCUI 865208

24 HR selegiline 0.25 MG/HR Transdermal System [Emsam] — RxCUI 865208

RxNorm drug concept · Semantic branded drug
RxCUI 865208 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI865208
Official name24 HR selegiline 0.25 MG/HR Transdermal System [Emsam]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEMSAM 6 MG/Day 24HR Transdermal System; 24 HR Emsam 0.25 MG/HR Transdermal System; Emsam 6 MG per 24 HR Transdermal Patch
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)984 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Selegiline Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Emsam is a prescription skin patch used to treat major depressive disorder (MDD) in adults. It belongs to a class of antidepressants called MAOIs — monoamine oxidase inhibitors — w...
  • What is the Emsam patch actually used for?
  • It depends on your dose. At the lowest dose, no special diet is required. But at the two higher doses, you do need to avoid foods high in tyramine — things like aged cheeses, cured...
  • Do I really need to avoid certain foods while wearing this patch?
📖 Read our full Selegiline Transdermal Patch guide →

🕸️ Concept Web — How 24 HR selegiline 0.25 MG/HR Transdermal System [... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR selegiline 0.25 MG/HR Transdermal System [Emsam] RxCUI 865208

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Selegiline 9639
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Emsam 617716
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Selegiline Transdermal System 1806068
    • Selegiline Topical Product 1158174
    • Selegiline Transdermal Product 1295063
    • Selegiline Transdermal System [Emsam] 1806071
    • Emsam Topical Product 1175941
    • Emsam Transdermal Product 1296229
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 24 HR selegiline 0.25 MG/HR Transdermal System SCD · 865206
  • Selegiline 0.25 MG/HR SCDC · 1806067
  • Selegiline Transdermal System SCDF · 1806068
  • Selegiline Topical Product SCDG · 1158174
  • Selegiline Transdermal Product SCDG · 1295063

Brand-Name Concepts

  • Selegiline 0.25 MG/HR [Emsam] SBDC · 1806070
  • Selegiline Transdermal System [Emsam] SBDF · 1806071
  • Emsam Topical Product SBDG · 1175941
  • Emsam Transdermal Product SBDG · 1296229
  • Emsam BN · 617716

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 865208 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49502-0900-05 5 POUCH in 1 CARTON (49502-900-05) / 1 PATCH in 1 POUCH (49... EMSAM Viatris Specialty LLC 2006-02-27
49502-0900-30 30 POUCH in 1 CARTON (49502-900-30) / 1 PATCH in 1 POUCH (4... EMSAM Viatris Specialty LLC 2006-02-27
49502-0901-30 30 POUCH in 1 CARTON (49502-901-30) / 1 PATCH in 1 POUCH (4... EMSAM Viatris Specialty LLC 2006-02-27
49502-0902-30 30 POUCH in 1 CARTON (49502-902-30) / 1 PATCH in 1 POUCH (4... EMSAM Viatris Specialty LLC 2006-02-27
Observed labelers: Viatris Specialty LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.